Lexaria Bioscience Corp
Research Lexaria Bioscience Corp (LEXX) on Bullrun: market cap USD 5.49M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLEXX
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 5.49M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 1.99M
- Free cash flow-USD 1.66M
Valuation Snapshot
latest market cap is USD 5.49M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 705.92K | -USD 11.90M | -USD 10.48M | 99.6% | -0.66 | USD 1.80M | USD 109.32K | USD 2.99M |
| FY2024 | USD 464.28K | -USD 5.80M | -USD 5.00M | 99.0% | -0.47 | USD 6.50M | USD 137.37K | USD 8.04M |
| FY2023 | USD 226.21K | -USD 6.66M | -USD 5.91M | 86.1% | -1.01 | USD 1.35M | USD 163.97K | USD 3.04M |
| FY2022 | USD 255.40K | -USD 7.27M | -USD 4.93M | 71.9% | -18.6 | USD 5.81M | USD 49.99K | USD 7.95M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 5.49M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 15.43M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 36.65M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 12.89M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 14.64M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 23.98M | n/a | n/a | n/a |
About Lexaria Bioscience Corp
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Lexaria Bioscience Corp's market cap?
Lexaria Bioscience Corp's market capitalization is USD 5.49M.
What does Lexaria Bioscience Corp do?
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods.